Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 14, 2023

SELL
$98.98 - $115.74 $254,378 - $297,451
-2,570 Reduced 84.85%
459 $53,000
Q2 2023

Aug 14, 2023

SELL
$96.34 - $112.38 $617,539 - $720,355
-6,410 Reduced 67.91%
3,029 $311,000
Q1 2023

May 09, 2023

BUY
$107.32 - $113.5 $335,482 - $354,801
3,126 Added 49.52%
9,439 $1.03 Million
Q4 2022

Feb 10, 2023

SELL
$62.39 - $113.8 $319,686 - $583,111
-5,124 Reduced 44.8%
6,313 $718,000
Q3 2022

Nov 10, 2022

SELL
$58.92 - $84.67 $226,252 - $325,132
-3,840 Reduced 25.14%
11,437 $708,000
Q2 2022

Aug 15, 2022

BUY
$79.4 - $116.36 $713,806 - $1.05 Million
8,990 Added 142.99%
15,277 $1.22 Million
Q1 2022

May 12, 2022

SELL
$86.42 - $109.81 $320,531 - $407,285
-3,709 Reduced 37.1%
6,287 $661,000
Q4 2021

Feb 14, 2022

BUY
$98.56 - $119.91 $827,411 - $1.01 Million
8,395 Added 524.36%
9,996 $1.08 Million
Q3 2021

Nov 15, 2021

SELL
$91.91 - $110.37 $1.18 Million - $1.41 Million
-12,806 Reduced 88.89%
1,601 $175,000
Q2 2021

Aug 16, 2021

BUY
$86.24 - $95.92 $935,962 - $1.04 Million
10,853 Added 305.37%
14,407 $1.35 Million
Q1 2021

May 17, 2021

SELL
$71.83 - $95.48 $199,543 - $265,243
-2,778 Reduced 43.87%
3,554 $327,000
Q4 2020

Feb 16, 2021

SELL
$67.0 - $84.39 $311,148 - $391,907
-4,644 Reduced 42.31%
6,332 $463,000
Q3 2020

Nov 16, 2020

BUY
$55.23 - $79.93 $551,913 - $798,740
9,993 Added 1016.58%
10,976 $853,000
Q2 2020

Aug 13, 2020

SELL
$30.2 - $56.98 $87,308 - $164,729
-2,891 Reduced 74.63%
983 $55,000
Q1 2020

May 15, 2020

BUY
$24.87 - $38.56 $83,364 - $129,253
3,352 Added 642.15%
3,874 $114,000
Q4 2019

Feb 07, 2020

SELL
$25.43 - $36.67 $54,572 - $78,693
-2,146 Reduced 80.43%
522 $19,000
Q3 2019

Nov 05, 2019

SELL
$23.0 - $27.97 $16,583 - $20,166
-721 Reduced 21.27%
2,668 $73,000
Q2 2019

Aug 13, 2019

BUY
$22.81 - $28.48 $77,303 - $96,518
3,389 New
3,389 $82,000

Others Institutions Holding HZNP

About Horizon Therapeutics Public Ltd Co


  • Ticker HZNP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 230,384,000
  • Description
  • Horizon Therapeutics Public Limited Company, a biotechnology company, focuses on the discovery, development, and commercialization of medicines that address critical needs for people impacted by rare, autoimmune, and severe inflammatory diseases. The company operates in two segments, Orphan and Inflammation. Its portfolio comprises 12 medicines ...
More about HZNP
Track This Portfolio

Track Tower Research Capital LLC (Trc) Portfolio

Follow Tower Research Capital LLC (Trc) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Tower Research Capital LLC (Trc), based on Form 13F filings with the SEC.

News

Stay updated on Tower Research Capital LLC (Trc) with notifications on news.